Ovarian cancer (OC) is a relatively fatal female reproductive malignancy. Since the underlying causes are uncertain, it brings us to believe that both genetic and external factors contribute toward development of this lethal disorder. Exposure to endocrine-disrupting chemicals (EDCs) in the form of occupational usage of pesticides, fungicides, herbicides, plasticizers, cosmetics, and so on is potentially carcinogenic and their ability to cause epigenetic modifications has led us to hypothesize that they may play a catalytic role in OC progression. In response to synthetic chemicals, animal models have demonstrated disturbances in the development of ovaries and steroid hormonal levels but in humans, more research is required. The present review is an attempt to address the impact of EDCs on the hormonal system and gene methylation levels that may lead to malfunctioning of the ovaries which may consequently develop in the form of cancer. It can be concluded that endocrine disruptors do have a potential carcinogenicity and their high proportions in human body may cause epigenetic modifications, prompting ovarian surface epithelium to grow in an abnormal manner.
Introduction
Ovarian cancer (OC) is the leading cause of death from gynecologic malignancies worldwide. 1 Incidences of hormonal cancers are continuously rising not only in the Western countries but also among the Asian nations in recent times. 2, 3 In females, OC is the seventh leading cause of cancer worldwide. 4 The rate of incidence varies across the continents; the highest being Europe, followed by North America, Australia and New Zealand, South America, Asia, and finally Africa. 5 Recently, a notable increase in rate of OC in Asia (Japan) and East/South Europe (Poland) while decrease in North America (US whites) and North Europe (Denmark) has been observed. 4 Delayed diagnosis at stage III/IV has become the fourth highest cause of OC mortality in women. 6 A recent study has estimated that 14 080 deaths would be attributed to OC in United States by the end of 2017. 7 A number of factors contribute toward the increased risk of OC, which includes genetic, reproductive, hormonal, and behavioral factors. 8 Hormones play a significant role in the growth of cancerous tissues which perhaps could be due to the imbalance in estrogen, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and androgen levels. 9 It is also estimated that about 90% of cancer is caused due to the environmental contaminants, 10 which includes exposure to ionizing radiation, 11 asbestos, 12 pesticides, 13, 14 and industrial effluents. 15 Many of these substances are endocrine-disrupting chemicals (EDCs) that may alter the functioning of the endocrine system leading to adverse health outcomes. 16 Exposure to these EDCs as particulate and gaseous vapors might trigger their interaction with endocrine glands and may also exert agonist or antagonist actions on hormone receptors. 17 By far, among the hormonal cancers, the research with respect to EDCs has largely focused on breast, endometrial, prostate, and testes cancer, whereas limited work has been done with respect to OC. 15 The recently developed field of epigenetics has explored some parameters in cancer biology and detection. However, very few studies have observed the effect of EDCs leading to epigenetic modifications in hormone receptor genes which could be responsible for tumor formation in ovaries. The current review is an attempt to address the impact of EDCs on the hormonal system and gene methylation levels (epigenetics) that may lead to malfunctioning of the ovaries which may consequently develop in the form of cancer. 
Ovarian Cancer and Its Origin
Till few years back, it was believed that OC is a single disease that originated in the ovaries, but advancements in molecular techniques led us to deduce that OC is a complex group of molecularly and etiologically distinct diseases sharing an anatomical location, that is, ovaries as the organs for progression. 18 It comprises of a heterogeneous group of tumors; the most common being the ovarian epithelial tumors accounting for about 90% of the cases. 19 Besides, nonepithelial OC is frequent in younger women where relatively earlier diagnosis and better prognosis is possible. Histologically, epithelial ovarian cancers (EOCs) are further differentiated into type I and type II subgroups. 20, 21 Morphologically, type I OCs are low-grade, well-differentiated, localized tumors characterized by genomic stability. These include low-grade serous and mucinous carcinoma, endometrioid carcinoma, clear cell carcinoma, and transitional carcinoma. 22 The tumor is either ovarian derived or may arise from preinvasive lesions of endometriosis associated with retrograde menstruation from the endometrial layer or cystadenoma. 18, 23 However, these lesions are not known to cause tumors of high grade. 22 Although type I OCs are stable at the overall genomic level, they frequently exhibit point mutations. 24, 25 These include mutations in Kirsten rat sarcoma viral oncogene homolog (KRAS), B-Raf protooncogene, serine/threonine kinase (BRAF), phosphatase and tensin homolog, catenin beta 1, AT rich interactive domain 1A [SWI-like] gene, and phosphatidylinositol-4,5-biphosphate 3-kinase genes. 26, 27 The more advanced type II OCs are high-grade, rather undifferentiated, metastasized tumors, reflecting genomic instability on account of tethered DNA repair capacity. 28 These are identified as high-grade serous adenocarcinoma, high-grade endometrioid carcinoma, carcinosarcoma, and undifferentiated carcinoma. The tumor arises from epithelial cells of both ovary and fallopian tube as a result of varying mutational events majorly inactivating mutations in p53 genes. 29 In addition, constitutive mutations in BRCA 1 and 2 genes; amplifications in KRAS, serine-threonine protein kinase, phosphatidylinositol 3 kinase, epithelial cell adhesion molecule, mitogenactivated kinase-like protein, vascular endothelial growth factor, NOTCH, regulatory-associated protein of (mammalian target of rapamycin) mTOR, human epidermal growth factor receptor 2 genes; and point mutations in BRAF, cyclin-dependent kinase, epidermal Growth Factor Receptor, retinoblastoma 1, platelet derived growth factor receptor, and neuroblastoma-RAS genes have been observed in type II OCs. 30 Almost 75% of the patients with OC are diagnosed under type II category where the treatment options involve surgical excision of the tumor accompanied by chemotherapy. As the fallopian tube is also involved in the carcinogenesis process, 31, 32 its removal may render an individual free of cancer. Still research in OC is in a transition phase with each new day adding something more than the previous.
Genetic Profiling of OC
Majorly, OC is considered to be a sporadic disease, but family history at times is regarded as one of the strongest risk factors in the screening process. Almost 10% to 15% of patients with OC have been diagnosed to have hereditary etiology. Somatic mutations in the tumor protein 53 (TP53) gene occur in almost half of all OCs. TP53 gene mutations change the building blocks in the protein produced from this gene. The tumor suppressor protein produced from this gene keeps a check on cell growth or growth in an uncontrolled manner. But altered protein with diminished activity is not efficiently able to regulate cell growth and division leading to the development of cancerous tumor. High-grade serous carcinoma has shown frequent association with TP53 mutations. 33 On the other hand, germline mutations are involved in more than one-fifth of cases with OC. Sixty-five percent to 85% of these mutations are in the breast cancer antigen1 (BRCA1) or BRCA2 genes. Along with breast cancer, there is an impressionable association of these genes with OC. 34 "High penetrance" is the name given to these mutations because they are associated with a high risk of developing OC, breast cancer, and several other types of cancers in women. Compared to a 1.6% lifetime risk of developing OC for women in the total population, the lifetime risk with a BRCA1 gene mutation is 40% to 60%, whereas the risk with BRCA2 gene mutation is 20% to 35%. 35 Germline mutations in dozens of other genes have been studied as possible risk factors for OC. The molecular alterations and signaling pathways observed in OC are summarized in Table 1 .
Testing for additional genetic risk factors for OC is an active area of medical research. However, planned community-based genetic testing in cases with OC can prove to be beneficial as it may provide information on the type of mutation (OC specific) prevalent in the community. This can aid in screening of the individuals of a population with respect to their community specific mutations.
Role of EDCs in OC
The previous section explored the genetics in OC, and the current section pertains to the influence of external environment in its causation. Of the various environmental contaminants, the most prevalent and the most discussed are the EDCs. The contact of EDCs with humans has become inevitable today. They are cosmopolitan and present from agriculture to industrial sectors, even in the day-to-day consumer products. 53, 54 An EDC may be defined as an exogenous agent that interferes with the synthesis, secretion, transport, binding, action, or elimination of natural hormones in the body that are responsible for the maintenance of homeostasis, reproduction, development and/or behavior. 55 A Endocrine-disrupting chemicals are emitted into the atmosphere during anthropogenic activities and physicochemical reactions in nature. Human exposure to EDCs might trigger their interaction with the endocrine glands which may lead to homeostasis misbalancing and dysregulation of gene expression. 59, 60 A probable link between exposures to EDCs and pathogenesis of OC is depicted in Figure 1 . Some of the well-known pesticides known to be endocrine disruptors are lindane, atrazine, diaminochlorotriazine, simazine, prochloraz, endosulfan, dieldrin, MXC, DDT, BPA, fenitrothion, 61 and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE). 62 Even the minute presence (nanogram levels) of EDCs is known to cause infertility, early puberty, obesity, diabetes, ovarian problems, thyroid eruptions, testicular carcinoma, Alzheimer disease, schizophrenia, nerve damage, and cancer. 16, 17, 63, 64 The susceptibility is known to increase with long-term exposure to the EDCs. 65 Gestational and perinatal exposure to EDCs may have long-term effect on the child after birth that can influence tumor development later in the child's life. [66] [67] [68] Dogan and Simsek depicted disturbance in estrogen metabolism on long-term exposure to low levels of EDCs. 69 The authors summarized that EDCs have a complex mode of action and are neither weak carcinogens nor weak estrogens. However, exposure time of the EDCs and characteristics of the target cells can determine the end point effect.
Many studies have depicted a link between pesticide exposure and OC. The Agricultural Health Study has stated an increase in OC risk among women who were employed as private pesticide applicators. 70, 71 In a study conducted in the United States, exposure to triazine herbicides also showed an increased risk to OC. 72 Furthermore, Lerro et al have reported an association of organophosphate diazinon with OC. 73 Similarly, MXC (an organochlorine pesticide) and triclosan (a preservative used in personal care products) have also been linked to OC. 74 Moreover, EDCs, namely, octylphenol, nonylphenol, and MXC that exhibit estrogenic activity have been reported to increase the growth of OC cells. 75 Studies conducted on animals and cell lines have given substantial evidence regarding connection of EDCs with OC. Experiments on mice have identified enhanced ovarian epithelial cancer cell proliferation and ovarian cyst and adenoma formation on exposure to BPA and HPTE. 76, 77 In various animal models, BPA was observed to cause an imbalance in the levels of sex steroid hormones by interfering with steroidogenesis. 78 Subchronic exposure of organophosphate-chlorpyrifos in female albino rats causes oxidative stress and negative effects on the reproductive organs, which may be a pointer toward the beginning of cancer incidence. 79 
Hormone Targets of EDCs and Their Association With OC
A broad spectrum of EDCs affects animals as well as human species, adversely. 80 Changes in sex steroid levels play a major role in progression of OC. 81 Several mechanisms have come into play behind the working of EDCs but the most prevalent mechanism is their interaction with hormone signaling pathways. 82 , 83 Zama and Uzumcu have pointed out the estrogenic, antiestrogenic, and antiandrogenic actions of hormones estradiol, progesterone, and androgens under the influence of EDCs. 84 Few in vitro studies have shown estrogen-like and antiandrogenic effects of a DDT metabolite by binding to nuclear receptors. 85, 86 It has been observed that plasticizers and pesticides, namely, BPA, nonylphenol, octylphenol, MXC, benzophenone-1 stimulate the proliferation of OC cells via estrogen signaling pathway. 75, 87 Estrogen is a steroid hormone that functions in multiple tissues in the body. 88 There might be a possibility of its involvement in the early stages of malignancy. According to Mungenast and coworkers, 89 the postmenopausal phase is marked by a decrease in the estrogen levels in ovaries but its parallel synthesis in circulation might affect cell proliferation and carcinogenesis in ovaries through transcriptional activation of nuclear receptors (ERa), activation of oncogenic signaling pathways, and generation of free radicals. Many studies have shown hormone therapy (HT) to be linked with OC. 90 According to Tsilidis et al, women undertaking HT in European continent are at a moderate risk of developing OC; the chances being higher for estrogen only (E) rather than estrogen and progesterone (E þ P) preparations taken together. 91 Similar finding was observed in Australian populations as well. 92 On the contrary, recent studies have suggested long-term use of both E and E þ P therapies to be associated with OC. 93, 94 Genital talc use was observed to be associated with OC, and it was suggested that estrogen and/or prolactin might have a role to play via macrophage activity causing an inflammatory response to talc. 95 Moreover, EDCs possessing estrogenic properties (genistein, BPA, HPTE, benzophenone, etc) may stimulate ER signaling leading to OC progression. 75, 87, 96 According to Cardenas et al, 97 the natural decline in estrogen levels in perimenopausal phase results in hypergonadotrophic conditions through negative feedback control which could also be responsible for ovarian tumorigenesis. Furthermore, it is proposed that EDCs with antiestrogenic effects may lead to increased production of gonadotropins in hypothalamus during menopausal/postmenopausal stage, which may directly stimulate the gonads and therefore may also impact the risk of OC development. 98, 99 Altogether, the true nature of estrogen and its contribution to ovarian carcinogenesis during postmenopausal phase is debatable and yet to be deciphered. Another class of hormones, the gonadotropins, namely, FSH and LH also control the reproductive functions. Aging causes degeneration of a woman's ovarian reserve, resulting in a complex of low levels of estrogen and progesterone, and high levels of gonadotropins as a characteristic feature in the early postmenopausal years, 100, 101 during which vulnerability to OC is on a rise. 97 Gonadotropins are known to play a role in ovarian carcinogenesis via activation of multiple molecular signaling pathways directly involved in proliferation and invasion. 102 The surge in gonadotropins may possibly occur on account of pelvic irradiation, ovarian infections, exposure to EDCs, use of exogenous gonadotropins as in fertility drugs and in vitro fertilization treatment. 98, 103, 104 In addition, the use of antiestrogenic compounds may also enhance the levels of gonadotropins in circulation, 98 which may have a role in proliferation, apoptosis, adhesion, invasion, and angiogenesis in epithelial OC. 99 Few studies have pointed out the potential role of pesticides in modulating gonadotropin levels. Chlorpyrifos and MXC may alter the synthesis of gonadotropin-releasing hormones. 105, 106 Ventura et al indicated that exposure to chlorpyrifos may further cause endocrine imbalance thereby posing a risk factor in reproductive cancer. 106 Owing to structural homology to hormone receptors, DDT and its metabolites are believed to disturb the normal functioning of gonadotropin hormones. 107 In addition, DDT analogs and MXC may stimulate oncogenic extracellular-signal regulated kinase pathway via the expression of FSH and LH. 108 The hormone androgen is known to decrease cell death and therefore affects cancer development in ovaries. 102 Studies have shown an overexpression of androgen receptors in OC cells. 109, 110 Some studies have linked the use of exogenous androgens with an increased risk of OC.
111,112 4-Nitro-3-phenylphenol, isolated from diesel exhaust particles, can act as androgen agonist as well as antagonist in rats leading to hormone-related problems. 113 Hormone progesterone exerts a protective effect in OC in contrast to the effects shown by the above-mentioned estrogen, androgen, and gonadotropin hormones. 81 Two receptor isoforms, namely, progesterone receptor A (PRA) and progesterone receptor B (PRB) function toward it. This occurs through suppression of proteins involved in tumor invasion and metastasis. 114, 115 Progesterone receptor B causes cell death in OC cells. 116 Since the phase of menopause is marked by decline in the levels of progesterone, it is very likely to increase the propensity of OC. 102 
Epigenetic Effects of EDCs in OC
Long-term exposure to harmful EDCs may bring about changes in the gene expression pattern on account of epigenetic modifications, resulting in adverse health outcomes. 117, 118 DNA methylation is one of the most commonly studied epigenetic marker involving covalent transfer of a methyl group to the C-5 position of the cytosine ring of DNA by DNA methyl transferases (DNMTs). 119 More than 98% of DNA methylation occurs in cytosine and guanine separated by phosphate (CpG) dinucleotide context in somatic cells, whereas as much as a quarter of all methylation appears in a non-CpG context in embryonic stem cells. 120 DNA methylation is essential for normal development, but when dysregulated, it contributes to diseases such as cancer. 121, 122 Access to environmental factors, namely, nutrition, stress, temperature, chemicals, and so on can cause epigenetic effects 123, 124 majorly in form of changes in DNA methylation, histone modifications, and noncoding RNAs. 125 A classical example can be seen in case of Agouti mouse where a provision of abnormal environment (nutrition) changed the DNA methylation pattern which eventually leads to the production of unhealthier pups. 126 Various studies have supported that both chemical and environmental toxins may alter DNA methylation patterns, resulting in epigenetic phenotypes. 127, 128 In case of reproductive cancers, many studies have displayed an association between EDCs and their effect on the epigenome. 129, 130 Romagnolo et al observed epigenetic changes in the tumor suppressor genes under the influence of endocrine disruptors in the case of breast cancer. 131 However, very few studies have dealt with the epigenetic actions of EDCs in the ovary. In a study by Zama and Uzumcu, 2 kinds of doses (low and high) of MXC were provided to the rat litters for 12 days. The effect was observed in their ovary in postnatal 50 to 60 days. Significant changes were detected upon treatment of high dose of MXC in adult ovaries in the form of hypermethylation of ERb, DNA methyl transferase 3 beta, pregnancyassociated plasma protein A genes. 132 Repression of ERb gene and increased activity of DNMT genes has been found in various types of cancers including OC under the influence of exogenous chemicals (herein MXC). 133, 134 Furthermore, it has been found that estrogen responsive genes (ERa and ERb) get modified under the influence of EDCs. 134 In this regard, Hall and Korach observed overexpression of ERa in OC. 96 According to Yoon, an abnormal response is generated as the EDC attaches to hormone receptors and causes an estrogenic effect 135 by either blocking the normal functioning of hormone or over or under production of hormones. 136 The so-called EDC-receptor complex formed may cause hypermethylation in the promoter region of hormone receptor genes leading to gene silencing. 137 If this holds true, studies can focus on the effect of EDCs on the DNA methylation pattern of genes involved in normal functioning of ovaries which may be of prognostic relevance in OC. A probable role of EDCs in altering the epigenome leading to regulation of gene expression is depicted in Figure 2 .
Perspective
With environmental changes, it is appalling to observe that even the middle-income countries are showing an increased incidence of OC. 138, 139 The agricultural dominant nations on account of ignorance follow unsafe farming practices, which can probably attribute to cause cancer among the rural communities across the globe. 140, 141 This poses an alarming situation for the population as a whole; as such hazardous pesticides infiltrate not only the bodies of the farmers (direct contact) but their families through passive contact, and the general public through the use of pesticides' sprayed food products.
It has been seen that EDCs have adapted quite well to the human body. 142 Exposure to EDCs when takes place during critical phases (developmental and menopausal/postmenopausal) may impair the normal functioning of female reproductive organs (ovaries). [143] [144] [145] Although adults require higher concentration of EDCs to cause any toxic effect, the developmental phase may be affected by low doses and buildup of such interaction with the environment can lead to appearance of diseases in later stages of life. 53 It is still not clear as to what amounts of EDCs define cancer-causing properties but it can be assumed that during menopause, when the ovaries are in a degenerating/low functioning state, they might get affected by exogenous chemicals in form of EDCs. In other words, there could be a possibility that ovaries being inactive in menopausal phase might become vulnerable to EDC attack. We can speculate that during menopausal/postmenopausal stage; when a low functioning ovary is coupled with long-term exposure to pesticides, a threshold might be surpassed, resulting in the manifestation of OC. If this is true, efforts should be made to make the general population aware of the harmful effects of those EDCs possessing antiestrogenic/ carcinogenic effects, which may directly stimulate the gonads and therefore may also impact the risk of OC development.
Lack of clear diagnostic pathways has made OC a significant health-care challenge and the most lethal of women's reproductive tract cancers. To a certain extent, DNA methylation signatures have been recognized as valuable diagnostic and prognostic OC biomarkers. Methylation assessment of a panel of antioncogenes (BRCA1, adenomatous polyposis coli, p16ink4a, and death-associated protein kinase) has been reported and can be applied with a high degree of specificity and sensitivity. [146] [147] [148] Gloss and Samimi have reported promoter methylation in tumor suppressor genes-BRCA1, homeobox protein HOX A9, Ras association domain-containing protein 1A, secreted protein acidic and cysteine rich, and hypermethylated in cancer protein 1 as potential markers for detection of aggressive and invasive forms of EOC. 149 However, further studies are required that can focus on identifying EDCs altering DNA methylation pattern of genes, which may provide an insight into the pathogenesis of OC.
The current scenario of OC can be dealt with the integrated efforts of anthropologists, gynecologists, endocrinologists, geneticists, and public health professionals to explain the harmful consequences of exposure to EDCs in reproductive health of women. Educating the women and the general population of the presence of toxic EDCs in common consumer products, levels, and timing of exposure to EDCs and ways of restricting it to the minimal should be propagated extensively by the health planners.
Conclusion
In summary, it is of prime concern to identify potential carcinogenic EDCs, which are still being overused in the name of meeting consumer demands for overgrowing population. Enforcement of stringent laws on the use of plasticizers and pesticides hazardous to human health is needed. Education needs to be spread at preliminary and high levels and to the occupationally exposed population who are innocently using pesticides, which consequently may lead to cancer not only in the immediate but also in their subsequent generations.
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